State Street SPDR S&P 600 Small Cap Growth ETF SLYG
110.23 USD -1.38 (-1.24%)
At closeNov 12, 2026, 4:00 PM EST
110.23 0.00 0.00%
After hours · Nov 12, 4:00 PM ET
110.13 Day range 111.66
88.67 52-week range 119.84
- YTD
- +17.03%
- 1 year
- +17.53%
News
defenseworld.net Asset Dedication LLC Purchases 5,748 Shares of SPDR S&P 600 Small Cap Growth ETF $SLYG Asset Dedication LLC acquired a new position in shares of SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) in the third quarter, according to its most recent 13F filing with the Securities and…
benzinga.com Viasat Wins US Space Force Satellite Contract Viasat (VSAT) stock jumps 6% after winning a major US Space Force contract for secure military satellite communications. Read the details.
benzinga.com What's Going on With Badger Meter On Monday? BMI Q1 FY26 results show adjusted EPS of $0.93 and sales of $202.3 million. Management cites project timing for the miss.
benzinga.com Badger Meter Stock Sinks To 52-Week Low - Here's Why Badger Meter (BMI) shares tank 20% after Q1 earnings and revenue miss. CEO cites project timing as stock hits a new 52-week low. Read more.
benzinga.com What's Going On With Hims & Hers Stock Tuesday? HIMS shares edge lower as CFO plans $5M stock sale. Get the latest on Hims & Hers technical analysis and premarket price action.
benzinga.com AeroVironment Scores Major Navy Contract, Stock Up AeroVironment (AVAV) shares rise after securing a U.S. Navy ISR services award for its JUMP 20-X VTOL platform. Read the full analysis.
benzinga.com Why Is MARA Stock Gaining Thursday? MARA Holdings, Inc. (NASDAQ: MARA) announced a major balance sheet move, selling $1.1 billion in Bitcoin to repurchase $1 billion in debt.
benzinga.com Hims & Hers Opens Waitlist For $149 Branded Wegovy And Ozempic Via Novo Nordisk Deal Hims & Hers Health, Inc. (NYSE:HIMS) trended on Wednesday after the company outlined an expanded weight-management push tied to
benzinga.com Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars Hims & Hers stock jumps 49% premarket after ending lawsuit with Novo Nordisk and securing weight-loss drug partnership.
benzinga.com Don't Forget About This Small-Cap Health Care ETF 
benzinga.com Buckle Earnings Preview: EPS and Sales Growth Expected 
benzinga.com DineEquity Earnings Preview: Q4 EPS Up 30%, Sales Down 19% Expected 
benzinga.com Cabela's Earnings Preview: Looking to Extend a Streak